.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
US Department of Justice
Queensland Health
Argus Health
Covington
McKesson
Colorcon
Merck
Deloitte
Medtronic

Generated: December 15, 2017

DrugPatentWatch Database Preview

Numark Company Profile

« Back to Dashboard

What is the competitive landscape for NUMARK, and what generic and branded alternatives to NUMARK drugs are available?

NUMARK has three approved drugs.



Summary for Numark

US Patents:0
Tradenames:4
Ingredients:1
NDAs:3
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
NumarkMELFIAT-105phendimetrazine tartrateCAPSULE, EXTENDED RELEASE;ORAL087487-001Oct 13, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
NumarkMELFIATphendimetrazine tartrateTABLET;ORAL083790-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
NumarkSPRX-105phendimetrazine tartrateCAPSULE, EXTENDED RELEASE;ORAL088024-001Dec 22, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
NumarkPHENDIMETRAZINE TARTRATEphendimetrazine tartrateTABLET;ORAL083790-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Colorcon
Deloitte
Chinese Patent Office
Harvard Business School
Teva
Chubb
Express Scripts
Federal Trade Commission
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot